PIPC issued the following statement in response to discussion on use of CER in Medicare payment policy at today’s meeting of the Medicare Payment Advisory Commission.
“Clinical evidence, and comparative effectiveness research (CER) in particular, can play a valuable role in empowering patients to make good decisions about the range of treatment options based on their unique circumstances and characteristics,” PIPC Chairman Tony Coelho said. “PIPC is concerned that expanded CMS authority to use CER in Medicare would result in one-size-fits-all policies that create patient access barriers. The discussion today highlights the importance of advancing principles of patient-centeredness in Medicare payment policy.”
“Clinical evidence, and comparative effectiveness research (CER) in particular, can play a valuable role in empowering patients to make good decisions about the range of treatment options based on their unique circumstances and characteristics,” PIPC Chairman Tony Coelho said. “PIPC is concerned that expanded CMS authority to use CER in Medicare would result in one-size-fits-all policies that create patient access barriers. The discussion today highlights the importance of advancing principles of patient-centeredness in Medicare payment policy.”
